Brief: Codex DNA Reports Q2 Loss Per Share $0.50
Aug 9 (Reuters) - Codex DNA Inc DNAY.O :
* CODEX DNA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.50
* Q2 REVENUE ROSE 98 PERCENT TO $5.7 MILLION
* CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS WERE
$61.9
MILLION AS OF JUNE 30, 2022
* SEES FY TOTAL REVENUE IN RANGE OF $22 MILLION TO $24
MILLION, UP
FROM PRIOR GUIDANCE OF $19 MILLION TO $21 MILLION
Source text for Eikon: ID:nGNXc4t5kT
Further company coverage: DNAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview